{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:24:12Z","timestamp":1778073852434,"version":"3.51.4"},"reference-count":15,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2022,9,28]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Using multiparametric flow cytometric analysis, in a cohort of 62 patients with classic Hodgkin lymphoma having a median follow-up period of 69.5 months, we found\u2014patients who experienced primary resistance or disease relapse (DR) had lower percentage of rosetted Hodgkin Reed-Sternberg cells (HRS-cells) as compared with patients who achieved sustained complete remission (SCR) (p=0.022); patients &gt;35 years of age had higher percentage of HRS-cells (p=0.017) and lower percentage of B cells (p=0.017) and the nodular sclerosis subtype had higher percentage of B-cells (p=0.046) and activated B-cells (p=0.03). The proportion of SCR and DR subsets did not differ by histological subtypes, disease stage or age groups.<\/jats:p>","DOI":"10.1136\/jcp-2022-208552","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T13:29:02Z","timestamp":1665754142000},"page":"414-417","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of risk of relapse in classic Hodgkin lymphoma"],"prefix":"10.1136","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-5284","authenticated-orcid":false,"given":"Jonathan R","family":"Fromm","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Tang","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-3638","authenticated-orcid":false,"given":"Kikkeri N","family":"Naresh","sequence":"additional","affiliation":[{"name":"Pathology \/ Cancer Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"2025112110263404000_76.6.414.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.4194"},{"key":"2025112110263404000_76.6.414.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.4589"},{"key":"2025112110263404000_76.6.414.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01314-1"},{"key":"2025112110263404000_76.6.414.4","unstructured":"Jachimowicz RD , Pieper L , Reinke S . Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica. 2020."},{"key":"2025112110263404000_76.6.414.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1207.004k34_1207_1213"},{"key":"2025112110263404000_76.6.414.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905680"},{"key":"2025112110263404000_76.6.414.7","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2359"},{"key":"2025112110263404000_76.6.414.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2012.03.028"},{"key":"2025112110263404000_76.6.414.9","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21261"},{"key":"2025112110263404000_76.6.414.10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025112110263404000_76.6.414.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024109"},{"key":"2025112110263404000_76.6.414.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168096"},{"key":"2025112110263404000_76.6.414.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.9881"},{"key":"2025112110263404000_76.6.414.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.06.006"},{"key":"2025112110263404000_76.6.414.15","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.951849"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2022-208552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:26:43Z","timestamp":1763749603000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2022-208552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,5,18]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/jcp-2022-208552"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2022-208552","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}